SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326732-23-000007
Filing Date
2023-06-15
Accepted
2023-06-14 17:55:44
Documents
12
Period of Report
2023-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20230614.htm   iXBRL 8-K 70180
  Complete submission text file 0001326732-23-000007.txt   208662

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20230614.xsd EX-101.SCH 1898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20230614_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20230614_pre.xml EX-101.PRE 12506
6 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20230614_htm.xml XML 12552
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 231015317
SIC: 2834 Pharmaceutical Preparations